Hypercortisolism Recognition and Action in Resistant Hypertension

In the final episode, ‘Hypercortisolism Recognition and Action in Resistant Hypertension,’ the panelists explored key takeaways from their discussion on the evolving role of hypercortisolism in resistant hypertension and cardiometabolic disease. Reflecting on the growing body of evidence linking cortisol excess to difficult-to-control hypertension, diabetes, and cardiovascular risk, the expert faculty emphasized the importance of rethinking traditional approaches to patient evaluation and management.

Throughout the discussion, the panel highlighted how emerging data have challenged long-held assumptions regarding secondary causes of hypertension. They acknowledged that many clinicians may not have routinely considered hypercortisolism when evaluating patients with resistant hypertension, obesity, difficult-to-control diabetes, or inadequate responses to standard therapies. As awareness increases, the panelists noted that opportunities exist to identify patients who may benefit from targeted evaluation and intervention.

The expert faculty discussed the potential clinical value of recognizing hypercortisolism earlier in the disease course. They emphasized that screening may uncover a treatable contributor to hypertension and cardiometabolic dysfunction, creating opportunities to improve outcomes and potentially reduce medication burden. The panel also reflected on the possibility that some patients may have underlying adrenal pathology or other forms of cortisol excess that can be addressed through specialized treatment approaches.

In their closing remarks, the panel of experts reinforced the importance of maintaining a high index of suspicion in patients with resistant hypertension. They encouraged clinicians to incorporate practical screening strategies into routine practice and highlighted the dexamethasone suppression test as a simple and accessible tool that may help identify patients requiring further endocrine evaluation. Ultimately, they emphasized that increased awareness, earlier recognition, and appropriate referral pathways may improve care for patients with hypercortisolism-associated hypertension. Thank you for watching this peer exchange series on hypercortisolism. Please subscribe to our newsletter for information on upcoming video series.